Laboratory Test Preparation

Test:Primary Immuno Def.Panel2 (BY APPOINTMENT PER PATIENT)
Other Test Request Name:
  • Natural Killer Cell
  • NK Cell
Test Composition:
  1. CD 3
  2. CD 16 CD 56
Intended Use:

Not Applicable

Methodology:

Flow Cytometry

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:
  • No patient preparation necessary.
  • Call Special Test Section (By Appointment/Schedule).

NOTE: Do not collect specimen without approval of Special Test Section

Collection/Sample Container:

EDTA or Violet Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 pcs of 4 mL whole blood

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

6 Hours

•   Refrigerated Temperature (2-8°C):

Not Applicable

•   Freezer Temperature (-20°C):

Not Applicable

Transport Temperature:

Transport specimen at 15°C ~25 °C (room temperature)

Rejection Criteria:
  • Exceeded sample stability requirement
  • Quantity not sufficient
  • Improperly labeled specimen
  • Improper collection tube used
  • Clotted Sample
  • Over-filled or Under-filled tube
Running Day:

Monday to Friday

Cut Off Time:

Monday to Friday, 7:00 AM

TAT/Releasing of Results:

7 days after running (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None Specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Immune system is missing or does not function normally

 

Test:Primary Immuno Def.Panel3 (BY APPOINTMENT)
Other Test Request Name:

T and B Cell w/ NK Cell

Test Composition:
  1. T and B Cell
  2. CD3
  3. CD4
  4. CD8
  5. CD4 and CD8 ratio
  6. CD19
  7. CD20
  8. CD16 56
Intended Use:Not Applicable
Methodology:

Flow Cytometry

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:
  • No patient preparation necessary.
  • Call Special Test Section (By Appointment/Schedule).

NOTE: Do not collect specimen without approval of Special Test Section

Collection/Sample Container:

EDTA or Violet Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 pcs of 4 mL whole blood

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

6 Hours

•   Refrigerated Temperature (2-8°C):

Not Applicable

•   Freezer Temperature (-20°C):

Not Applicable

Transport Temperature:

Transport specimen at 15°C ~25 °C (room temperature)

Rejection Criteria:
  • Exceeded sample stability requirement
  • Quantity not sufficient
  • Improperly labeled specimen
  • Improper collection tube used
  • Clotted Sample
  • Over-filled or Under-filled tube
Running Day:

Monday to Friday

Cut Off Time:

Monday to Friday, 7:00 AM 

TAT/Releasing of Results:

7 days after running (excluding Saturdays, Sundays and Holidays)

 

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None Specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Immune system is missing or does not function normally

 

Test:Primary Immuno Def.Panel4 (BY APPOINTMENT PER PATIENT)
Other Test Request Name:

Not Applicable

Test Composition:
  1. CD4
  2. CD8
  3. CD4/CD8 Ratio
Intended Use:Not Applicable
Methodology:

Flow Cytometry

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:
  • No patient preparation necessary.
  • Call Special Test Section (By Appointment/Schedule).

NOTE: Do not collect specimen without approval of Special Test Section

Collection/Sample Container:

EDTA or Violet Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 pcs of 4 mL whole blood

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

6 Hours

•   Refrigerated Temperature (2-8°C):

Not Applicable

•   Freezer Temperature (-20°C):

Not Applicable

Transport Temperature:

Transport specimen at 15°C ~25 °C (room temperature)

Rejection Criteria:
  • Exceeded sample stability requirement
  • Quantity not sufficient
  • Improperly labeled specimen
  • Improper collection tube used
  • Clotted Sample
  • Over-filled or Under-filled tube
Running Day:

Monday to Friday

Cut Off Time:

Monday to Friday, 7:00 AM

TAT/Releasing of Results:

7 days after running (excluding Saturdays, Sundays and Holidays)

 

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None Specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Immune system is missing or does not function normally

 

Test:Primary Immuno Def.Panel5 (BY APPOINTMENT PER PATIENT)
Other Test Request Name:

Not Applicable

Test Composition:
  1. CD4
  2. CD8
  3. CD19
Intended Use:Not Applicable
Methodology:

Flow Cytometry

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:
  • No patient preparation necessary.
  • Call Special Test Section (By Appointment/Schedule.

NOTE: Do not collect specimen without approval of Special Test Section

Collection/Sample Container:

EDTA or Violet Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 pcs of 4 mL whole blood

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

6 Hours

•   Refrigerated Temperature (2-8°C):

Not Applicable

•   Freezer Temperature (-20°C):

Not Applicable

Transport Temperature:

Transport specimen at 15°C ~25 °C (room temperature)

 

Rejection Criteria:
  • Exceeded sample stability requirement
  • Quantity not sufficient
  • Improperly labeled specimen
  • Improper collection tube used
  • Clotted Sample
  • Over-filled or Under-filled tube
Running Day:

Monday to Friday

Cut Off Time:

Monday to Friday, 7:00 AM 

TAT/Releasing of Results:

7 days after running (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None Specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Immune system is missing or does not function normally

 

Test:Primary Immuno Def.Panel6 (BY APPOINTMENT PER PATIENT)
Other Test Request Name:

Not Applicable

Test Composition:

1. CD19
2. CD20 Pan B-Cells (B1)

Intended Use:Not Applicable
Methodology:

Flow Cytometry

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:
  • No patient preparation necessary.
  • Call Special Test Section (By Appointment/Schedule).

NOTE: Do not collect specimen without approval of Special Test Section

Collection/Sample Container:

EDTA or Violet Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 pcs of 4 mL whole blood

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

6 Hours

•   Refrigerated Temperature (2-8°C):

Not Applicable

•   Freezer Temperature (-20°C):

Not Applicable

Transport Temperature:

Transport specimen at 15°C ~25 °C (room temperature)

Rejection Criteria:
  • Exceeded sample stability requirement
  • Quantity not sufficient
  • Improperly labeled specimen
  • Improper collection tube used
  • Clotted Sample
  • Over-filled or Under-filled tube
Running Day:

Monday to Friday

Cut Off Time:

Monday to Friday, 7:00 AM

TAT/Releasing of Results:

7 days after running (excluding Saturdays, Sundays and Holidays)

 

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None Specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

immune system is missing or does not function normally

 

Test:Pro Insulin
Other Test Request Name:

Not applicable

Test Composition:

Not applicable

Intended Use:

Proinsulin is the precursor of insulin and the C peptide. Normally, about 5% of the proinsulin stored in granules in beta cells is released directly into the portal circulation instead of being converted in situ into insulin but this fraction can increase if insulin synthesis in the beta cells is stimulated for a prolonged period. In patients with Type II diabetes, especially the obese, the level of this prohormone is significantly elevated.

Methodology:

Radio Immuno Assay (RIA)

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:

No patient preparation necessary.

Collection/Sample Container:

Red or Gold Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 mL Serum

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

8 Hours

•   Refrigerated Temperature (2-8°C):

7 Days

•   Freezer Temperature (-20°C):

28 Days

Transport Temperature:

Transport specimen at 2 – 8 °C (with cold packs)

Rejection Criteria:

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Running Day:

Batch Running

Cut Off Time:

Friday 4:00 PM

TAT/Releasing of Results:

14 days after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Insulin, FBS, GlycoMark, DM

 

Test:Procalcitonin (ECLIA)
Other Test Request Name:

PCT

Test Composition:

Not applicable

Intended Use:
  • Biomarker associated with the inflammatory response to bacterial infection that aids in the risk assessment of critically ill patients on their first day of ICU admission for progression to serve sepsis and septic shock.
  • Helps distinguish between bacterial and non-bacterial causes of infections, such as meningitis and pneumonia
  • Helps guide in antibiotic treatment and or monitor effectiveness of treatment
Methodology:

Electrochemiluminescence Immunoassay (ECLIA)

Laboratory Section:

Immunology

Special Instructions/Patient Preparations:

Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5.00 mg/day) until at least 8 hours following the last biotin administration.

Collection/Sample Container:

Red or Gold tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

1-3 mL Serum

Alternative Specimen and Volume Requirement:

1-3mL Plasma (Li-Heparin, K2 EDTA, K3 EDTA)

Specimen Stability  
•   Room Temperature (15-25°C):

Not specified

•   Refrigerated Temperature (2-8°C):

24 hours

•   Freezer Temperature (-20°C):

3 months(Freeze and thaw only once)

Transport Temperature:

Transport specimen at 2°C – 8 °C (with cold packs)

Rejection Criteria:
  • Improper collection tube used
  • Specimen stored/transported outside the temperature range
  • Quantity not sufficient
  • Improperly labeled specimen
  • Markedly lipemic specimen
Running Day:

Monday to Saturday

Cut Off Time:

Monday to Saturday: 6:00 pm

TAT/Releasing of Results:

ROUTINE (on running days)
• 4 hours after receipt of specimen/ arrival of messenger
STAT (on running days only)
• 2½ hours from extraction/messenger arrival

Reference Interval/Result Interpretation:
  • <0.50 ng/mL - minimize the likelihood of sepsis or severe sepsis
  • 0.50~2.00 ng/mL - “Grayzone”. Bacterial infection cannot be ruled out. Suggest repeat testing in 6 to 24 hours for monitoring if sepsis is clinically considered.
  • >2.00 ng/mL – indicate a high likelihood of severe sepsis or septic shock.
Limitations/Interferences:

• In rare cases, interference due to extremely high titers of antibodies to analyte specific antibodies, streptavidin or ruthenium can occur. These effects are minimized by suitable test design.
• PCT levels can be increased in certain situations without infectious origin. These include, but are not limited to:
1. prolonged or severe cardiogenic shock
2. prolonged severe organ perfusion anomalies
3. small cell lung cancer or medullary C cell carcinoma of the thyroid
4. early after major trauma, major surgical intervention, severe burns
5. treatments which stimulate the release of pro inflammatory cytokines
6. neonates (<48 hours after birth)
• For diagnostic purposes, the results should always be assessed in
conjunction with the patient’s medical history, clinical examination and other

Frequently Asked Questions (FAQs):

Q: Who is at risk of sepsis?
A: Sepsis is more common in newborns, infants, and in the elderly, but other people at risk include post-surgery patients, people with internal medical devices such as catheters, people with chronic conditions such as diabetes, and people with weakened immune systems. Though less common, even healthy children and adults can develop sepsis from an infection that can progress if not recognized early and treated.

Q: What types of infections can lead to sepsis?
Infections that most commonly lead to sepsis include those of the lung (pneumonia), urinary tract, skin, and digestive tract. Common bacteria that can trigger sepsis include Staphylococcus aureus, Escherichia coli (E. coli), and some types of Streptococcus.

Q: What other tests may be done if a systemic bacterial infection or sepsis is suspected?
Other tests may include cultures (e.g. blood culture, urine culture or cultures of other body fluids), complete blood count (CBC), lactate, blood gases, comprehensive metabolic panel (CMP), prothrombin time (PT) and/or partial thromboplastin time (PTT) and C-reactive protein (CRP).

Related Words/Test:

CBC, CRP, Blood culture, Urine Culture, CSF analysis, Lactate, Blood gases

 

Test:Procollagen Type-1(ECLIA)
Other Test Request Name:
  • Intact N-Terminal propeptide of type I procollagen
  • Intact procollagen type I (N-propeptide)
Test Composition:

Not applicable

Intended Use:

Very sensitive bone model marker. Used to monitor the efficiency of osteoporosis treatment, by the anabolic molecule, 1-34 fragment of human recobinant pth, which indicates severe oesteoporosis fractures.

Methodology:

Electrochemiluminescence

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:

Interference possible in patients treated with biotin (vitamin B7, B8 or H) or taking any food supplement containing biotin. Essential to STOP treatment 8 days before taking the sample.

Collection/Sample Container:

Red or Gold Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 mL Serum

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

Not applicable

•   Refrigerated Temperature (2-8°C):

27 Days

•   Freezer Temperature (-20°C):

60 Days

Transport Temperature:

Transport specimen at 2 – 8 °C (with cold packs)

Rejection Criteria:

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Running Day:

Batch Running

Cut Off Time:

Friday 4:00 PM

TAT/Releasing of Results:

14 days after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Collagen type I, steoporosis and monitoring bone formation therapies and antiresorptive therapies.

 

Test:Progesterone (ECLIA)
Other Test Request Name:

• Progesterone
• PGSN

Test Composition:

Not applicable

Intended Use:

• Utilized in fertility diagnosis for the detection of ovulation and assessment of the luteal phase.
• Used in evaluation of pregnant patients with 1st trimester bleeding and of infertility, monitoring of ovulation.

Methodology:

Electrochemiluminescence Immunoassay (ECLIA)

Laboratory Section:

Immunology

Special Instructions/Patient Preparations:

•Non-Fasting
•Samples should be taken at least 8 hours in patient's receiving therapy with high biotin doses (>5mg/day

Collection/Sample Container:

Red or Gold tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

1-3mL Serum

Alternative Specimen and Volume Requirement:

1-3 mL Plasma  (Li heparin/ K2-EDTA/ K3 EDTA)

Specimen Stability  
•   Room Temperature (15-25°C):

1 Day

•   Refrigerated Temperature (2-8°C):

5 Days

•   Freezer Temperature (-20°C):

6 Months

Transport Temperature:

Transport specimen at 2°C – 8 °C (with cold packs)

Rejection Criteria:

• Hemolyzed specimen
• Lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Running Day:

Monday, Friday

Cut Off Time:

Monday to Saturday: 10:00 PM

Sunday: 6:00PM

TAT/Releasing of Results:

ROUTINE (on running days)
• 4 hours after receipt of specimen/ arrival of messenger
STAT (on running days only)
• 2½ hours from extraction/messenger arrival

Reference Interval/Result Interpretation:

• Male: <0.05 – 0.149 ng/mL
• Female (Non Pregnant):
Follicular Phase: 0.057 – 0.893 ng/mL
Ovulation Phase: 0.121 – 12.00 ng/mL
Luteal Phase: 1.83 – 23.90 ng/mL
Post-menopausal Phase: <0.05 – 0.126 ng/mL
• Female (Pregnant)
1st trimester: 11.00 – 44.30 ng/mL
2nd trimester: 25.40 – 83.30 ng/mL
3rd trimester: 58.70 – 214.00 ng/mL

Limitations/Interferences:

• Visibly turbid samples give a false low result.
• Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration.
• Phenylbutazone at therapeutic dosage levels showed interference with the assay (progesterone values depressed).
• In rare cases, interference due to extremely high titers of antibodies to analyte specific antibodies, streptavidin or ruthenium can occur.

Frequently Asked Questions (FAQs):

Not applicable

Related Words/Test:

Fertility Testing, Estrogens, hCG Pregnancy, FSH, LH

 

Test:Prolactin (ECLIA)
Other Test Request Name:

• Prolactin
• PRL

Test Composition:

Not applicable

Intended Use:

•Determine the cause of breast milk production not associated with pregnancy or breast-feeding (galactorrhea)
•Diagnose the cause of infertility and erectile dysfunction in men
•Diagnose the cause of menstrual irregularities and/or infertility in women
•Detect and diagnose tumors that produce excess prolactin (prolactinomas), monitor their treatment, and detect recurrences
•Evaluate anterior pituitary function or other pituitary disorder

Methodology:

Electrochemiluminescence Immunoassay (ECLIA)

Laboratory Section:

Immunology

Special Instructions/Patient Preparations:

•Non Fasting
•Samples should be collected 3-4 hrs after waking.
NOTE: Prolactin levels vary throughout the day and night — highest during sleep, just after waking up, following strenuous exercise, and during periods of emotional stress — your doctor may request that the test be performed at a certain time of day (usually 3-4 hours after waking up).

Collection/Sample Container:

Red or Gold tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

1-3mL Serum

Alternative Specimen and Volume Requirement:

1-3 mL Plasma (Li-heparin/ K3-EDTA)

Specimen Stability  
•   Room Temperature (15-25°C):

Not specified

•   Refrigerated Temperature (2-8°C):

14 Days

•   Freezer Temperature (-20°C):

6 Months (Freeze only once)

Transport Temperature:

Transport specimen at 2°C – 8 °C (with cold packs)

Rejection Criteria:

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Running Day:

Monday, Wednesday, Friday

Cut Off Time:

Monday to Saturday: 10:00 PM

Sunday: 6:00PM

TAT/Releasing of Results:

ROUTINE (on running days)
• 4 hours after receipt of specimen/ arrival of messenger
STAT (on running days only)
• 2½ hours from extraction/messenger arrival

Reference Interval/Result Interpretation:

Male: 86-324 mIU/L
Female: 102-496 mIU/L

Limitations/Interferences:

• The release of prolactin is promoted physiologically by suckling and stress. In addition, elevated serum prolactin concentrations are caused by a number of pharmaceuticals (e.g. dibenzodiazepines, phenothiazine), TRH, and estrogen.
• The release of prolactin is inhibited by dopamine, L-dopa and ergotamine derivatives.
• A number of publications report the presence of macroprolactin in the serum of female patients with various endocrinological diseases or during pregnancy. Macroprolactin may cause falsely elevated results of Prolactin. Results should always be assessed in conjunction with the patient’s medical history, clinical examination and other findings.

Frequently Asked Questions (FAQs):

Not applicable

Related Words/Test:

Fertility Testing, FSH, LH, Testosterone, DHEAS, Estrogens, Progesterone, Androstenedione

 

Test:Prolactin (RIA)
Other Test Request Name:

Not applicable

Test Composition:

Not applicable

Intended Use:

Diagnosis and management of pituitary adenoma. Investigation of hypogonadism

Methodology:

Radio Immuno Assay (RIA)

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:

8 hours fasting is preferred.

Collection/Sample Container:

Red or Gold Tube

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

3 mL Serum

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

5 Days

•   Refrigerated Temperature (2-8°C):

7 Days

•   Freezer Temperature (-20°C):

28 Days

Transport Temperature:

Transport specimen at 2 – 8 °C (with cold packs)

Rejection Criteria:

• Hemolyzed specimen
• Markedly lipemic specimen
• Exceeded sample stability requirement
• Quantity not sufficient
• Improperly labeled specimen
• Improper collection tube used

Running Day:

Wednesday 8:00 AM

Cut Off Time:

Tuesday 4:00 PM

TAT/Releasing of Results:

3 days after running day (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Pituitary gland in the brain, lactogenic hormone

 

Test:Prolaris-Temporarily Unavailable (currently not accepting samples)
Other Test Request Name:

Not applicable

Test Composition:

Not applicable

Intended Use:

• Prolaris testing should be done following an affirmative biopsy and prostate cancer diagnosis.
• Prolaris is a genomic test that can help your physician predict prostate cancer aggressiveness, especially used in combination with the usual clinical features, such as Gleason score or PSA.
• Prolaris measures the activity of genes involved with tumor growth to predict disease outcome. At cancer diagnosis, a Prolaris test on biopsy tissue can help identify patients with less aggressive prostate cancer who may be candidates for less aggressive, or limited, treatment.
• Prolaris can identify patients who appear clinically low-risk but have a more aggressive disease that may require more treatment.
• Prolaris can be used in patients in whom the prostate was removed, helps to better estimate the likelihood that the disease may recur.

Methodology:

Gene Expression Analysis by RT-PCR

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:

No patient preparation necessary.

Collection/Sample Container:

Slide holders or mailers for microscope slides; FFPE tissue blocks can either be wrapped in paper or placed in a box.

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

• Formalin-fixed paraffin-embedded (FFPE) tissue block
• 1 H&E stained slide representative of the submitted tissue block.
• Histopathology report for the submitted tissue block

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

Indefinite

•   Refrigerated Temperature (2-8°C):

Not applicable

•   Freezer Temperature (-20°C):

Not applicable

Transport Temperature:

• Microscope slides should be placed in slide holders or mailers and should be adequately padded before placing in a shipping/packaging container to prevent breakage.
• FFPE tissue blocks must be placed in a box and avoid direct sunlight to prevent melting and disorientation during transport or shipping.
• Transport specimen at 15°C ~25 °C (room temperature)

Rejection Criteria:

• Incomplete information in the Request Form
• Improper or insufficient labeling of tissue blocks or slides
• Inadequate tissue available on the tissue block

Running Day:

Mondays to Thursdays

Cut Off Time:

11:00 AM

TAT/Releasing of Results:

24 days (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Not Applicable

Limitations/Interferences:

None specified.

Frequently Asked Questions (FAQs):

Not Applicable

Related Words/Test:

Prostate cancer

 

Test:Propoxyphene
Other Test Request Name:Not applicable
Test Composition:Not applicable
Intended Use:Used as a screening test for qualitative detection of propoxyphene in urine.
Methodology:Lateral Flow Immunochromatography (Competitive Binding)
Laboratory Section:Drug Test
Special Instructions/Patient Preparations:No patient preparation necessary
Collection/Sample Container:60-mL clean, screw cap, polyethylene container
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:60 mL urine
Alternative Specimen and Volume Requirement:Not applicable
Specimen Stability  
•   Room Temperature (15-25°C):Not specified
•   Refrigerated Temperature (2-8°C):48 Hours
•   Freezer Temperature (-20°C):Not specified
Transport Temperature:Not applicable
Rejection Criteria:• Incompatibility of the ID number on the specimen received by the laboratory with the number on the CCF.
• Absence of ID number on the specimen
• No printed Authorized Specimen Collector’s name and signature on the CCF.
• Broken or tampered seal on the specimen container
• Insufficient quantity of specimen, below 60 mL for single collection; below 30 mL for spilt collection
Running Day:Daily
Cut Off Time:Monday to Saturday
• 6:00 PM

Sunday
• 3:00 PM
TAT/Releasing of Results:ROUTINE
• 3 hours after receipt of specimen/ arrival of messenger
STAT
• After 1½ hours from receipt of specimen/ arrival of messenger
Reference Interval/Result Interpretation:Not applicable
Limitations/Interferences:• Other drugs with the same structure with the abused drugs
• Cross-reactant chemicals
• Bleach or alum
Frequently Asked Questions (FAQs):Not applicable
Related Words/Test:Dextropropoxyphene, analgesic

 

Test:Prostate w/ Pre-Post Void Ultrasound
Other Test Request Name:

-

Test Composition:Not Applicable
Intended Use:
Ultrasound imaging or sonography is considered to be a non-invasive procedure and does not involve ionizing radiation which is usual in X-rays. An ultrasound scan is not only useful in assessing the structure of organs and different internal structures but can also show the movement of organs in real time.
 
It may be used to assess the size and location of organs and structures of the following:
  • Urinary Bladder
  • Prostate Gland
Methodology:Not Applicable
Laboratory Section:Not Applicable
Special Instructions/Patient Preparations:

PREPARATION

  • Fasting is not required.
  • Avoid drinking colored drinks for at least 6 hours.
  • Full bladder is required prior the procedure.

SPECIAL INSTRUCTIONS

  • The staff from Imaging Department will instruct the patient as to when to start drinking water (at least 1 liter) when he/she is about to be called in queue; while taking note of the following:
  • If patient is not done with blood extraction, patient is not yet allowed to drink water.
  • If patient has not yet collected sample for urinalysis, patient is advised to drink 1 to 2 cups of water.
  • If patient's condition requires a certain amount of liquid intake.
  • Bring previous ultrasound result for comparison.
Collection/Sample Container:Not Applicable
Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:Not Applicable
Alternative Specimen and Volume Requirement:Not Applicable
Specimen Stability  
•   Room Temperature (15-25°C):Not Applicable
•   Refrigerated Temperature (2-8°C):Not Applicable
•   Freezer Temperature (-20°C):Not Applicable
Transport Temperature:Not Applicable
Rejection Criteria:Not Applicable
Running Day:Not Applicable
Cut Off Time:Not Applicable
TAT/Releasing of Results:

-

Reference Interval/Result Interpretation:

-

Limitations/Interferences:Not Applicable
Frequently Asked Questions (FAQs):

-

Related Words/Test:Not Applicable

 

Test:Protein 14.3.3
Other Test Request Name:

• Codon 129 prion protein-genotype

• Creutzfeldt- Jackob

Test Composition:

Not Applicable

Intended Use:

• The 14-3-3η protein appears to contribute to the pathologic process of joint erosion and, as such, is an emerging biomarker of joint damage in rheumatoid arthritis (RA) and psoriatic arthritis. Concentrations are significantly higher in people with active joint disease than in those with inactive RA or psoriasis without arthritis. Measurement of 14-3-3η complements RF and CCP antibody tests and may improve diagnostic sensitivity.

Methodology:

Western - Blot

Laboratory Section:

Special Test

Special Instructions/Patient Preparations:

No patient preparation necessary.

Collection/Sample Container:

Sterile Container

Specimen and Volume Requirement
Note:Follow tube manufacturer recommendation.		:

2 mL Cerebrospinal Fluid (CSF)

Alternative Specimen and Volume Requirement:

Not Applicable

Specimen Stability  
•   Room Temperature (15-25°C):

4 Days

•   Refrigerated Temperature (2-8°C):

7 Days

•   Freezer Temperature (-20°C):

21 Days

Transport Temperature:

Transport specimen at 2 – 8 °C (with cold packs)

Rejection Criteria:

• Insufficient volume
• Incorrect storage and transport temperature of specimen
• Insufficient volume
• Incorrect collection container used
• Improperly labeled specimen

Running Day:

Batch Running

Cut Off Time:

Friday 4:00 PM

TAT/Releasing of Results:

1-2 months after cut-off (excluding Saturdays, Sundays and Holidays)

Reference Interval/Result Interpretation:

Available upon request

Limitations/Interferences:

None specified.

Frequently Asked Questions (FAQs):

Not applicable

Related Words/Test:

Creutzfeldt-Jackob